Inside UCSF takes a quick look at some of the biggest stories of 2013 that highlight the University and the campus community.
December 20, 2013
December 18, 2013
Research led by scientists at the UCSF-affiliated Gladstone Institutes has identified the precise chain of molecular events in the human body that drives the death of most of the immune system’s CD4 T cells as an HIV infection leads to AIDS. Further, they have identified an existing anti-inflammatory drug that in laboratory tests blocks the death of these cells.
December 18, 2013
A new study provides further proof that regular use of the the HIV antiretroviral drug Truvada can reduce one’s risk for contracting HIV – without increasing sexual risk behavior.
December 03, 2013
Over more than two decades in Africa, UCSF researchers have approached their scientific work with a dual aim: treat disease while helping to sustainably build up the local health care system.
November 25, 2013
After heading the Obama administration’s global effort on AIDS, Eric Goosby is returning to his roots at UCSF to apply his experiences to improving public health programs.
November 06, 2013
David Baltimore, PhD, will present the 2013 Gladstone Distinguished Lecture on Wednesday, Nov. 20. The lecture, titled, “The Role of MicroRNAs in Immune Functions,” will begin at 4 p.m. in Gladstone’s Robert Mahley Auditorium.
October 01, 2013
UCSF researchers received six of 78 awards announced this week by the National Institutes of Health for innovative, high-risk, high-reward research.
September 30, 2013
Three Gladstone scientists have won research awards from divisions of the National Institutes of Health equaling an approximate total of $12.5 million over five years for their groundbreaking research to overcome HIV/AIDS.
July 11, 2013
With 10 days to go before AIDS Walk San Francisco, UCSF is working to get members of the University community to sign up for or contribute to the annual fundraiser to support programs and services to treat and prevent HIV/AIDS.
July 10, 2013
A new study by UCSF researchers points to changes in intestinal bacteria as a possible explanation for why successfully treated HIV patients nonetheless experience life-shortening chronic diseases.